Last 12 months
Inside the activity.
0 purchase rows · 6 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 21, 2023 Filed Sep 25, 2023 21:03 UTC |
Nierenberg MichaelDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 106,545 | $9.30 | $990,868.50 |
DisclosureSEC source: 0001209191-23-050490 · doc4.xml · nonDerivative · entry 1 Nierenberg Michael · CIK 0001591719 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,313,796 F1 · shares: Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding in connection with the settlement of restricted stock awards and does not represent a sale by the reporting person. F2 · balance_after: Includes 485,279 unvested restricted stock units and 385,356 unvested shares of restricted stock. Read SEC document |
| July 28, 2023 Filed Aug 1, 2023 20:21 UTC |
Sivin Philip MChief Legal Officer
|
GrantCommon Stock | 332 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-043965 · doc4.xml · nonDerivative · entry 1 Sivin Philip M · CIK 0001299722 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,264 F1 · shares: Represents dividend equivalent rights accrued on existing time-based restricted stock units, the grant of which was previously reported, in connection with the issuer's quarterly dividend. Such dividend equivalent units will vest on the same schedule and subject to the same terms and conditions as the underlying awards. F2 · balance_after: Includes 13,864 unvested restricted stock units. Read SEC document |
| July 28, 2023 Filed Aug 1, 2023 20:24 UTC |
Nierenberg MichaelDirector · Chief Executive Officer
|
GrantCommon Stock | 11,642 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-043969 · doc4.xml · nonDerivative · entry 1 Nierenberg Michael · CIK 0001591719 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,420,341 F1 · shares: Represents dividend equivalent rights accrued on existing time-based restricted stock units, the grant of which was previously reported, in connection with the issuer's quarterly dividend. Such dividend equivalent units will vest on the same schedule and subject to the same terms and conditions as the underlying awards. F2 · balance_after: Includes 485,279 unvested restricted stock units and 578,034 unvested shares of restricted stock. Read SEC document |
| July 28, 2023 Filed Aug 1, 2023 20:19 UTC |
SANTORO NICOLA JRChief Financial Officer
|
GrantCommon Stock | 1,663 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-043960 · doc4.xml · nonDerivative · entry 1 SANTORO NICOLA JR · CIK 0001571610 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 119,325 F1 · shares: Represents dividend equivalent rights accrued on existing time-based restricted stock units, the grant of which was previously reported, in connection with the issuer's quarterly dividend. Such dividend equivalent units will vest on the same schedule and subject to the same terms and conditions as the underlying awards. F2 · balance_after: Includes 69,325 unvested restricted stock units. Read SEC document |
| May 26, 2023 Filed May 30, 2023 20:24 UTC |
Hebard Peggy HwanDirector
|
GrantCommon Stock | 18,604 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032883 · doc4.xml · nonDerivative · entry 1 Hebard Peggy Hwan · CIK 0001750581 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,604 F1 · price: The shares were issued to director as compensation for services provided to the Issuer in accordance with the Issuer's Omnibus Incentive Plan and the additional terms established by resolution of the Board of Directors. The applicable closing stock price was $8.17 on May 26, 2023. Read SEC document |
| May 26, 2023 Filed May 30, 2023 20:23 UTC |
Finnerty Kevin JDirector
|
GrantCommon Stock | 18,972 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032881 · doc4.xml · nonDerivative · entry 1 Finnerty Kevin J · CIK 0001335440 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 281,080 F1 · price: The shares were issued to director as compensation for services provided to the Issuer in accordance with the Issuer's Omnibus Incentive Plan and the additional terms established by resolution of the Board of Directors. The applicable closing stock price was $8.17 on May 26, 2023. Read SEC document |
| May 26, 2023 Filed May 30, 2023 20:35 UTC |
Le Melle Patrice MDirector
|
GrantCommon Stock | 18,360 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032899 · doc4.xml · nonDerivative · entry 1 Le Melle Patrice M · CIK 0001894131 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,234 F1 · price: The shares were issued to director as compensation for services provided to the Issuer in accordance with the Issuer's Omnibus Incentive Plan and the additional terms established by resolution of the Board of Directors. The applicable closing stock price was $8.17 on May 26, 2023. Read SEC document |
| May 26, 2023 Filed May 30, 2023 20:26 UTC |
Sloves AndrewDirector
|
GrantCommon Stock | 18,972 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032886 · doc4.xml · nonDerivative · entry 1 Sloves Andrew · CIK 0001679934 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 156,477 F1 · price: The shares were issued to director as compensation for services provided to the Issuer in accordance with the Issuer's Omnibus Incentive Plan and the additional terms established by resolution of the Board of Directors. The applicable closing stock price was $8.17 on May 26, 2023. Read SEC document |
| May 26, 2023 Filed May 30, 2023 20:21 UTC |
Saltzman DavidDirector
|
GrantCommon Stock | 19,584 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032876 · doc4.xml · nonDerivative · entry 1 Saltzman David · CIK 0001574248 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,274 F1 · price: The shares were issued to director as compensation for services provided to the Issuer in accordance with the Issuer's Omnibus Incentive Plan and the additional terms established by resolution of the Board of Directors. The applicable closing stock price was $8.17 on May 26, 2023. F1 · balance_after: The shares were issued to director as compensation for services provided to the Issuer in accordance with the Issuer's Omnibus Incentive Plan and the additional terms established by resolution of the Board of Directors. The applicable closing stock price was $8.17 on May 26, 2023. Read SEC document |
| May 10, 2023 Filed May 10, 2023 20:20 UTC |
Hebard Peggy HwanDirector
|
GrantCommon Stock | 32,000 | $7.94 | $254,080.00 |
DisclosureSEC source: 0001209191-23-028476 · doc4.xml · nonDerivative · entry 1 Hebard Peggy Hwan · CIK 0001750581 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,000 Read SEC document |
| April 28, 2023 Filed May 2, 2023 20:32 UTC |
Sivin Philip MChief Legal Officer
|
GrantCommon Stock | 402 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-026520 · doc4.xml · nonDerivative · entry 1 Sivin Philip M · CIK 0001299722 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,932 F1 · shares: Represents dividend equivalent rights accrued on existing time-based restricted stock units, the grant of which was previously reported, in connection with the issuer's quarterly dividend. Such dividend equivalent units will vest on the same schedule and subject to the same terms and conditions as the underlying awards. F2 · balance_after: Includes 13,532 unvested restricted stock units. Read SEC document |
| April 28, 2023 Filed May 2, 2023 20:33 UTC |
Nierenberg MichaelDirector · Chief Executive Officer
|
GrantCommon Stock | 14,079 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-026528 · doc4.xml · nonDerivative · entry 1 Nierenberg Michael · CIK 0001591719 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,408,699 F1 · shares: Represents dividend equivalent rights accrued on existing time-based restricted stock units, the grant of which was previously reported, in connection with the issuer's quarterly dividend. Such dividend equivalent units will vest on the same schedule and subject to the same terms and conditions as the underlying awards. F2 · balance_after: Includes 473,637 unvested restricted stock units and 578,034 unvested shares of restricted stock. Read SEC document |
| April 28, 2023 Filed May 2, 2023 20:30 UTC |
SANTORO NICOLA JRChief Financial Officer
|
GrantCommon Stock | 2,011 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-026512 · doc4.xml · nonDerivative · entry 1 SANTORO NICOLA JR · CIK 0001571610 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 117,662 F1 · shares: Represents dividend equivalent rights accrued on existing time-based restricted stock units, the grant of which was previously reported, in connection with the issuer's quarterly dividend. Such dividend equivalent units will vest on the same schedule and subject to the same terms and conditions as the underlying awards. F2 · balance_after: Includes 67,662 unvested restricted stock units. Read SEC document |
| February 21, 2023 Filed Feb 23, 2023 21:16 UTC |
Sivin Philip MChief Legal Officer
|
GrantCommon Stock | 13,130 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-012156 · doc4.xml · nonDerivative · entry 1 Sivin Philip M · CIK 0001299722 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,530 F1 · shares: Represents time-based restricted stock units granted under the Rithm Capital Corp. Nonqualified Stock Option and Incentive Award Plan, which will vest in three equal annual installments on February 21 of each of 2024, 2025 and 2026, so long as the Reporting Person remains in continued employment with the Issuer. F2 · balance_after: Includes 13,130 unvested restricted stock units. Read SEC document |
| February 21, 2023 Filed Feb 23, 2023 21:22 UTC |
Nierenberg MichaelDirector · Chief Executive Officer
|
GrantCommon Stock | 459,558 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-012175 · doc4.xml · nonDerivative · entry 1 Nierenberg Michael · CIK 0001591719 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,394,620 F1 · shares: Represents time-based restricted stock units granted under the Rithm Capital Corp. Nonqualified Stock Option and Incentive Award Plan, which will vest in three equal annual installments on February 21 of each of 2024, 2025 and 2026, so long as the Reporting Person remains in continued employment with the Issuer. F2 · balance_after: Includes 459,558 unvested restricted stock units and 578,034 unvested shares of restricted stock. Read SEC document |
| February 21, 2023 Filed Feb 23, 2023 21:19 UTC |
SANTORO NICOLA JRChief Financial Officer
|
GrantCommon Stock | 65,651 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-012164 · doc4.xml · nonDerivative · entry 1 SANTORO NICOLA JR · CIK 0001571610 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,651 F1 · shares: Represents time-based restricted stock units granted under the Rithm Capital Corp. Nonqualified Stock Option and Incentive Award Plan, which will vest in three equal annual installments on February 21 of each of 2024, 2025 and 2026, so long as the Reporting Person remains in continued employment with the Issuer. F2 · balance_after: Includes 65,651 unvested restricted stock units. Read SEC document |
| January 04, 2023 Filed Jan 4, 2023 22:51 UTC |
Sloves AndrewDirector
|
GrantCommon Stock | 15,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-001274 · doc4.xml · nonDerivative · entry 1 Sloves Andrew · CIK 0001679934 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,505 F1 · price: The shares were issued to the Reporting Person as compensation for services as a director provided to the issuer in accordance with the issuer's Incentive Award Plan and the additional terms established by resolution of the Board of Directors. The applicable closing stock price was $8.17 on December 30, 2022. Read SEC document |
| December 08, 2022 Filed Dec 9, 2022 20:44 UTC |
Nierenberg MichaelDirector · Chairman, CEO & President
|
GrantCommon Stock | 578,034 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-060467 · doc4.xml · nonDerivative · entry 1 Nierenberg Michael · CIK 0001591719 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 935,062 F1 · shares: Represents restricted stock awards granted under the Rithm Capital Corp. Nonqualified Stock Option and Incentive Award Plan, which will vest in three equal installments on June 17 of each of 2023, 2024 and 2025, so long as the Reporting Person remains in continued employment with the Issuer. As previously disclosed, the restricted stock was granted in full satisfaction of the terms of Section 2(d) of the Employment Agreement by and between the Reporting Person and the Issuer, effective as of June 17, 2022. The applicable closing stock price was $8.65 on June 17, 2022. F2 · balance_after: Includes 578,034 unvested shares of restricted stock. Read SEC document |
| June 30, 2022 Filed Jul 1, 2022 11:23 UTC |
Finnerty Kevin JDirector
|
GrantCommon Stock | 8,048 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-039992 · doc4.xml · nonDerivative · entry 1 Finnerty Kevin J · CIK 0001335440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262,108 F1 · price: The shares were issued to director as compensation for services provided to the issuer in accordance with the issuer's Incentive Award Plan and the additional terms established by resolution of the Board of Directors. The applicable closing stock price was $9.32 on June 30, 2022 Read SEC document |
| June 30, 2022 Filed Jul 1, 2022 11:10 UTC |
Sloves AndrewDirector
|
GrantCommon Stock | 8,048 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-039990 · doc4.xml · nonDerivative · entry 1 Sloves Andrew · CIK 0001679934 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,205 F1 · price: The shares were issued to director as compensation for services provided to the issuer in accordance with the issuer's Incentive Award Plan and the additional terms established by resolution of the Board of Directors. The applicable closing stock price was $9.32 on June 30, 2022. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 20:16 UTC |
LENEHAN PAMELA FDirector
|
GrantCommon Stock | 9,761 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-033144 · doc4.xml · nonDerivative · entry 1 LENEHAN PAMELA F · CIK 0001202481 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,953 F1 · price: The shares were issued to director as compensation for services provided to the issuer in accordance with the issuer's Incentive Award Plan and the additional terms established by resolution of the Board of Directors. The applicable closing stock price was $11.27 on May 27, 2022. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 20:15 UTC |
Finnerty Kevin JDirector
|
GrantCommon Stock | 8,874 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-033143 · doc4.xml · nonDerivative · entry 1 Finnerty Kevin J · CIK 0001335440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,060 F1 · price: The shares were issued to director as compensation for services provided to the issuer in accordance with the issuer's Incentive Award Plan and the additional terms established by resolution of the Board of Directors. The applicable closing stock price was $11.27 on May 27, 2022. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 16:16 UTC |
MCGINNIS ROBERTDirector
|
GrantCommon Stock | 8,874 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-033146 · doc4.xml · nonDerivative · entry 1 MCGINNIS ROBERT · CIK 0001525863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,865 F1 · price: The shares were issued to director as compensation for services provided to the issuer in accordance with the issuer's Incentive Award Plan and the additional terms established by resolution of the Board of Directors. The applicable closing stock price was $11.27 on May 27, 2022. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 20:19 UTC |
Le Melle Patrice MDirector
|
GrantCommon Stock | 8,874 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-033151 · doc4.xml · nonDerivative · entry 1 Le Melle Patrice M · CIK 0001894131 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,874 F1 · price: The shares were issued to director as compensation for services provided to the issuer in accordance with the issuer's Incentive Award Plan and the additional terms established by resolution of the Board of Directors. The applicable closing stock price was $11.27 on May 27, 2022. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 20:18 UTC |
Sloves AndrewDirector
|
GrantCommon Stock | 8,874 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-033150 · doc4.xml · nonDerivative · entry 1 Sloves Andrew · CIK 0001679934 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,157 F1 · price: The shares were issued to director as compensation for services provided to the issuer in accordance with the issuer's Incentive Award Plan and the additional terms established by resolution of the Board of Directors. The applicable closing stock price was $11.27 on May 27, 2022. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 20:17 UTC |
Saltzman DavidDirector
|
GrantCommon Stock | 8,874 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-033148 · doc4.xml · nonDerivative · entry 1 Saltzman David · CIK 0001574248 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,690 F1 · price: The shares were issued to director as compensation for services provided to the issuer in accordance with the issuer's Incentive Award Plan and the additional terms established by resolution of the Board of Directors. The applicable closing stock price was $11.27 on May 27, 2022. Read SEC document |
| March 17, 2022 Filed Mar 17, 2022 22:41 UTC |
Nierenberg MichaelDirector · Chairman, CEO & President
|
GrantStock Option (right to buy) · Derivative | 3,567 | $0.00 Strike: $11.16 | $0.00 |
DisclosureSEC source: 0001209191-22-019759 · doc4.xml · derivative · entry 4 Nierenberg Michael · CIK 0001591719 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,567 Underlying: Common Stock, par value $0.01 per share · 3,567 shares Expires 2031-11-10 F1 · derivative.exercise_date: Tandem awards correspond on a one-to-one basis with options granted to FIG LLC, the Company's manager (or an affiliate of the Company's manager), such that exercise by an employee of the tandem award would result in the corresponding option held by the manager being cancelled. Upon the grant of options to the manager (or an affiliate), such options are fully vested and become exercisable over a 30-month period (the "Total Exercisability Period") in monthly installments beginning on the first of each month following the month in which the options were granted. (Continued in Footnote 2) F2 · derivative.exercise_date: When tandem awards are granted with respect to manager options, the manager options become exercisable in monthly installments over a portion of the Total Exercisability Period equal to the product of (i) the ratio of manager options not subject to corresponding tandem options to the total number of manager options (including manager options underlying such tandem awards subject to corresponding tandem options) multiplied by (ii) 30 (such period, the "Manager Exercisability Period"). Following the Manager Exercisability Period, the tandem awards vest in monthly installments on the first of each month over the remainder of the Total Exercisability Period and become exercisable only at the end of the Total Exercisability Period. F3 · derivative.expiration_date: Represents the expiration date of the related manager option. In general, the expiration date of the tandem award occurs prior to the expiration date of the underlying option. F4 · derivative.underlying: Tandem awards will be settled in an amount of cash equal to the excess of the fair market value of a share of our common stock on the date of exercise over the fair market value on the date of grant, unless advance approval is given by the Board of Directors or an officer of the Company, as applicable, to settle the tandem awards in shares. Read SEC document |
| March 17, 2022 Filed Mar 17, 2022 22:41 UTC |
Nierenberg MichaelDirector · Chairman, CEO & President
|
GrantStock Option (right to buy) · Derivative | 32,000 | $0.00 Strike: $10.54 | $0.00 |
DisclosureSEC source: 0001209191-22-019759 · doc4.xml · derivative · entry 3 Nierenberg Michael · CIK 0001591719 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,000 Underlying: Common Stock, par value $0.01 per share · 32,000 shares Expires 2031-09-24 F1 · derivative.exercise_date: Tandem awards correspond on a one-to-one basis with options granted to FIG LLC, the Company's manager (or an affiliate of the Company's manager), such that exercise by an employee of the tandem award would result in the corresponding option held by the manager being cancelled. Upon the grant of options to the manager (or an affiliate), such options are fully vested and become exercisable over a 30-month period (the "Total Exercisability Period") in monthly installments beginning on the first of each month following the month in which the options were granted. (Continued in Footnote 2) F2 · derivative.exercise_date: When tandem awards are granted with respect to manager options, the manager options become exercisable in monthly installments over a portion of the Total Exercisability Period equal to the product of (i) the ratio of manager options not subject to corresponding tandem options to the total number of manager options (including manager options underlying such tandem awards subject to corresponding tandem options) multiplied by (ii) 30 (such period, the "Manager Exercisability Period"). Following the Manager Exercisability Period, the tandem awards vest in monthly installments on the first of each month over the remainder of the Total Exercisability Period and become exercisable only at the end of the Total Exercisability Period. F3 · derivative.expiration_date: Represents the expiration date of the related manager option. In general, the expiration date of the tandem award occurs prior to the expiration date of the underlying option. F4 · derivative.underlying: Tandem awards will be settled in an amount of cash equal to the excess of the fair market value of a share of our common stock on the date of exercise over the fair market value on the date of grant, unless advance approval is given by the Board of Directors or an officer of the Company, as applicable, to settle the tandem awards in shares. Read SEC document |
| March 17, 2022 Filed Mar 17, 2022 22:41 UTC |
Nierenberg MichaelDirector · Chairman, CEO & President
|
GrantStock Option (right to buy) · Derivative | 340,000 | $0.00 Strike: $10.54 | $0.00 |
DisclosureSEC source: 0001209191-22-019759 · doc4.xml · derivative · entry 2 Nierenberg Michael · CIK 0001591719 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 340,000 Underlying: Common Stock, par value $0.01 per share · 340,000 shares Expires 2031-09-17 F1 · derivative.exercise_date: Tandem awards correspond on a one-to-one basis with options granted to FIG LLC, the Company's manager (or an affiliate of the Company's manager), such that exercise by an employee of the tandem award would result in the corresponding option held by the manager being cancelled. Upon the grant of options to the manager (or an affiliate), such options are fully vested and become exercisable over a 30-month period (the "Total Exercisability Period") in monthly installments beginning on the first of each month following the month in which the options were granted. (Continued in Footnote 2) F2 · derivative.exercise_date: When tandem awards are granted with respect to manager options, the manager options become exercisable in monthly installments over a portion of the Total Exercisability Period equal to the product of (i) the ratio of manager options not subject to corresponding tandem options to the total number of manager options (including manager options underlying such tandem awards subject to corresponding tandem options) multiplied by (ii) 30 (such period, the "Manager Exercisability Period"). Following the Manager Exercisability Period, the tandem awards vest in monthly installments on the first of each month over the remainder of the Total Exercisability Period and become exercisable only at the end of the Total Exercisability Period. F3 · derivative.expiration_date: Represents the expiration date of the related manager option. In general, the expiration date of the tandem award occurs prior to the expiration date of the underlying option. F4 · derivative.underlying: Tandem awards will be settled in an amount of cash equal to the excess of the fair market value of a share of our common stock on the date of exercise over the fair market value on the date of grant, unless advance approval is given by the Board of Directors or an officer of the Company, as applicable, to settle the tandem awards in shares. Read SEC document |
| March 17, 2022 Filed Mar 17, 2022 22:41 UTC |
Nierenberg MichaelDirector · Chairman, CEO & President
|
GrantStock Option (right to buy) · Derivative | 1,034,500 | $0.00 Strike: $9.75 | $0.00 |
DisclosureSEC source: 0001209191-22-019759 · doc4.xml · derivative · entry 1 Nierenberg Michael · CIK 0001591719 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,034,500 Underlying: Common Stock, par value $0.01 per share · 1,034,500 shares Expires 2031-04-19 F1 · derivative.exercise_date: Tandem awards correspond on a one-to-one basis with options granted to FIG LLC, the Company's manager (or an affiliate of the Company's manager), such that exercise by an employee of the tandem award would result in the corresponding option held by the manager being cancelled. Upon the grant of options to the manager (or an affiliate), such options are fully vested and become exercisable over a 30-month period (the "Total Exercisability Period") in monthly installments beginning on the first of each month following the month in which the options were granted. (Continued in Footnote 2) F2 · derivative.exercise_date: When tandem awards are granted with respect to manager options, the manager options become exercisable in monthly installments over a portion of the Total Exercisability Period equal to the product of (i) the ratio of manager options not subject to corresponding tandem options to the total number of manager options (including manager options underlying such tandem awards subject to corresponding tandem options) multiplied by (ii) 30 (such period, the "Manager Exercisability Period"). Following the Manager Exercisability Period, the tandem awards vest in monthly installments on the first of each month over the remainder of the Total Exercisability Period and become exercisable only at the end of the Total Exercisability Period. F3 · derivative.expiration_date: Represents the expiration date of the related manager option. In general, the expiration date of the tandem award occurs prior to the expiration date of the underlying option. F4 · derivative.underlying: Tandem awards will be settled in an amount of cash equal to the excess of the fair market value of a share of our common stock on the date of exercise over the fair market value on the date of grant, unless advance approval is given by the Board of Directors or an officer of the Company, as applicable, to settle the tandem awards in shares. Read SEC document |
| January 04, 2022 Filed Jan 4, 2022 21:21 UTC |
LENEHAN PAMELA FDirector
|
GrantCommon Stock | 10,028 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-000734 · doc4.xml · nonDerivative · entry 1 LENEHAN PAMELA F · CIK 0001202481 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,487 F1 · price: The shares were issued to director as compensation for services provided to the issuer in accordance with the issuer's Incentive Award Plan and the additional terms established by resolution of the Board of Directors. The applicable closing stock price was $10.97 on January 3, 2022. Read SEC document |
| January 04, 2022 Filed Jan 4, 2022 16:21 UTC |
MCGINNIS ROBERTDirector
|
GrantCommon Stock | 9,116 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-000742 · doc4.xml · nonDerivative · entry 1 MCGINNIS ROBERT · CIK 0001525863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,991 F1 · price: The shares were issued to director as compensation for services provided to the issuer in accordance with the issuer's Incentive Award Plan and the additional terms established by resolution of the Board of Directors. The applicable closing stock price was $10.97 on January 3, 2022. Read SEC document |
| January 04, 2022 Filed Jan 4, 2022 21:22 UTC |
Sloves AndrewDirector
|
GrantCommon Stock | 9,116 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-000749 · doc4.xml · nonDerivative · entry 1 Sloves Andrew · CIK 0001679934 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,283 F1 · price: The shares were issued to director as compensation for services provided to the issuer in accordance with the issuer's Incentive Award Plan and the additional terms established by resolution of the Board of Directors. The applicable closing stock price was $10.97 on January 3, 2022. Read SEC document |
| December 15, 2021 Filed Dec 15, 2021 21:15 UTC |
Le Melle Patrice MDirector
|
GrantStock Option (right to buy) · Derivative | 1,000 | $0.00 Strike: $10.85 | $0.00 |
DisclosureSEC source: 0001209191-21-069758 · doc4.xml · derivative · entry 1 Le Melle Patrice M · CIK 0001894131 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Underlying: Common Stock · 1,000 shares Expires 2031-12-15 F1 · price: Non-officer Director Stock options were granted pursuant to the issuer's Nonqualified Option and Incentive Award Plan (the "Plan"). Such options are fully vested in accordance with the terms of the Plan. F1 · derivative.exercise_date: Non-officer Director Stock options were granted pursuant to the issuer's Nonqualified Option and Incentive Award Plan (the "Plan"). Such options are fully vested in accordance with the terms of the Plan. Read SEC document |
| November 23, 2021 Filed Nov 23, 2021 16:17 UTC |
MCGINNIS ROBERTDirector
|
PurchaseSeries D Preferred Shares | 4,000 | $25.18 | $100,726.00 |
DisclosureSEC source: 0001209191-21-066413 · doc4.xml · nonDerivative · entry 1 MCGINNIS ROBERT · CIK 0001525863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Read SEC document |
| May 28, 2021 Filed Jun 1, 2021 16:20 UTC |
JACOBS DOUGLAS LDirector
|
GrantCommon Stock | 9,452 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-036820 · doc4.xml · nonDerivative · entry 1 JACOBS DOUGLAS L · CIK 0001195064 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,090 F1 · price: The shares were issued to director as compensation for services provided to the issuer in accordance with the issuer's Incentive Award Plan and the additional terms established by resolution of the Board of Directors. The applicable closing stock price was $10.58 on May 28, 2021. Read SEC document |
| May 28, 2021 Filed Jun 1, 2021 20:17 UTC |
LENEHAN PAMELA FDirector
|
GrantCommon Stock | 10,397 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-036812 · doc4.xml · nonDerivative · entry 1 LENEHAN PAMELA F · CIK 0001202481 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,459 F1 · price: The shares were issued to director as compensation for services provided to the issuer in accordance with the issuer's Incentive Award Plan and the additional terms established by resolution of the Board of Directors. The applicable closing stock price was $10.58 on May 28, 2021. Read SEC document |
| May 28, 2021 Filed Jun 1, 2021 20:18 UTC |
Finnerty Kevin JDirector
|
GrantCommon Stock | 9,452 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-036814 · doc4.xml · nonDerivative · entry 1 Finnerty Kevin J · CIK 0001335440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,032 F1 · price: The shares were issued to director as compensation for services provided to the issuer in accordance with the issuer's Incentive Award Plan and the additional terms established by resolution of the Board of Directors. The applicable closing stock price was $10.58 on May 28, 2021. Read SEC document |
| May 28, 2021 Filed Jun 1, 2021 16:21 UTC |
MCGINNIS ROBERTDirector
|
GrantCommon Stock | 9,452 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-036822 · doc4.xml · nonDerivative · entry 1 MCGINNIS ROBERT · CIK 0001525863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,875 F1 · price: The shares were issued to director as compensation for services provided to the issuer in accordance with the issuer's Incentive Award Plan and the additional terms established by resolution of the Board of Directors. The applicable closing stock price was $10.58 on May 28, 2021. Read SEC document |
| May 28, 2021 Filed Jun 1, 2021 20:21 UTC |
Saltzman DavidDirector
|
GrantCommon Stock | 9,452 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-036824 · doc4.xml · nonDerivative · entry 1 Saltzman David · CIK 0001574248 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,816 F1 · price: The shares were issued to director as compensation for services provided to the issuer in accordance with the issuer's Incentive Award Plan and the additional terms established by resolution of the Board of Directors. The applicable closing stock price was $10.58 on May 28, 2021. Read SEC document |
| May 28, 2021 Filed Jun 1, 2021 20:17 UTC |
Sloves AndrewDirector
|
GrantCommon Stock | 9,452 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-036809 · doc4.xml · nonDerivative · entry 1 Sloves Andrew · CIK 0001679934 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,167 F1 · price: The shares were issued to director as compensation for services provided to the issuer in accordance with the issuer's Incentive Award Plan and the additional terms established by resolution of the Board of Directors. The applicable closing stock price was $10.58 on May 28, 2021. Read SEC document |
| April 19, 2021 Filed Apr 19, 2021 20:15 UTC |
Nierenberg MichaelDirector · Chairman, CEO & President
|
PurchaseCommon Stock | 100,000 | $10.10 | $1,010,000.00 |
DisclosureSEC source: 0001209191-21-027279 · doc4.xml · nonDerivative · entry 1 Nierenberg Michael · CIK 0001591719 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 357,028 F1 · kind: Shares were purchased in connection with the Issuer's public offering of common stock. Read SEC document |
| March 16, 2021 Filed Mar 17, 2021 20:18 UTC |
Nierenberg MichaelDirector · Chairman, CEO & President
|
GrantStock Option (right to buy) · Derivative | 1,553 | $0.00 Strike: $17.02 | $0.00 |
DisclosureSEC source: 0001209191-21-021321 · doc4.xml · derivative · entry 4 Nierenberg Michael · CIK 0001591719 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,553 Underlying: Common Stock, par value $0.01 per share · 1,553 shares Expires 2030-02-28 F1 · derivative.exercise_date: Tandem awards correspond on a one-to-one basis with options granted to FIG LLC, the Company's manager (or an affiliate of the Company's manager), such that exercise by an employee of the tandem award would result in the corresponding option held by the manager being cancelled. Upon the grant of options to the manager (or an affiliate), such options are fully vested and become exercisable over a 30-month period (the "Total Exercisability Period") in monthly installments beginning on the first of each month following the month in which the options were granted. (Continued in Footnote 2) F2 · derivative.exercise_date: When tandem awards are granted with respect to manager options, the manager options become exercisable in monthly installments over a portion of the Total Exercisability Period equal to the product of (i) the ratio of manager options not subject to corresponding tandem options to the total number of manager options (including manager options underlying such tandem awards subject to corresponding tandem options) multiplied by (ii) 30 (such period, the "Manager Exercisability Period"). Following the Manager Exercisability Period, the tandem awards vest in monthly installments on the first of each month over the remainder of the Total Exercisability Period and become exercisable only at the end of the Total Exercisability Period. F3 · derivative.expiration_date: Represents the expiration date of the related manager option. In general, the expiration date of the tandem award occurs prior to the expiration date of the underlying option. F4 · derivative.underlying: Tandem awards will be settled in an amount of cash equal to the excess of the fair market value of a share of our common stock on the date of exercise over the fair market value on the date of grant, unless advance approval is given by the Board of Directors or an officer of the Company, as applicable, to settle the tandem awards in shares. Read SEC document |
| March 16, 2021 Filed Mar 17, 2021 20:18 UTC |
Nierenberg MichaelDirector · Chairman, CEO & President
|
GrantStock Option (right to buy) · Derivative | 394 | $0.00 Strike: $17.23 | $0.00 |
DisclosureSEC source: 0001209191-21-021321 · doc4.xml · derivative · entry 3 Nierenberg Michael · CIK 0001591719 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 394 Underlying: Common Stock, par value $0.01 per share · 394 shares Expires 2030-02-27 F1 · derivative.exercise_date: Tandem awards correspond on a one-to-one basis with options granted to FIG LLC, the Company's manager (or an affiliate of the Company's manager), such that exercise by an employee of the tandem award would result in the corresponding option held by the manager being cancelled. Upon the grant of options to the manager (or an affiliate), such options are fully vested and become exercisable over a 30-month period (the "Total Exercisability Period") in monthly installments beginning on the first of each month following the month in which the options were granted. (Continued in Footnote 2) F2 · derivative.exercise_date: When tandem awards are granted with respect to manager options, the manager options become exercisable in monthly installments over a portion of the Total Exercisability Period equal to the product of (i) the ratio of manager options not subject to corresponding tandem options to the total number of manager options (including manager options underlying such tandem awards subject to corresponding tandem options) multiplied by (ii) 30 (such period, the "Manager Exercisability Period"). Following the Manager Exercisability Period, the tandem awards vest in monthly installments on the first of each month over the remainder of the Total Exercisability Period and become exercisable only at the end of the Total Exercisability Period. F3 · derivative.expiration_date: Represents the expiration date of the related manager option. In general, the expiration date of the tandem award occurs prior to the expiration date of the underlying option. F4 · derivative.underlying: Tandem awards will be settled in an amount of cash equal to the excess of the fair market value of a share of our common stock on the date of exercise over the fair market value on the date of grant, unless advance approval is given by the Board of Directors or an officer of the Company, as applicable, to settle the tandem awards in shares. Read SEC document |
| March 16, 2021 Filed Mar 17, 2021 20:18 UTC |
Nierenberg MichaelDirector · Chairman, CEO & President
|
GrantStock Option (right to buy) · Derivative | 42,000 | $0.00 Strike: $17.41 | $0.00 |
DisclosureSEC source: 0001209191-21-021321 · doc4.xml · derivative · entry 2 Nierenberg Michael · CIK 0001591719 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,000 Underlying: Common Stock, par value $0.01 per share · 42,000 shares Expires 2030-02-25 F1 · derivative.exercise_date: Tandem awards correspond on a one-to-one basis with options granted to FIG LLC, the Company's manager (or an affiliate of the Company's manager), such that exercise by an employee of the tandem award would result in the corresponding option held by the manager being cancelled. Upon the grant of options to the manager (or an affiliate), such options are fully vested and become exercisable over a 30-month period (the "Total Exercisability Period") in monthly installments beginning on the first of each month following the month in which the options were granted. (Continued in Footnote 2) F2 · derivative.exercise_date: When tandem awards are granted with respect to manager options, the manager options become exercisable in monthly installments over a portion of the Total Exercisability Period equal to the product of (i) the ratio of manager options not subject to corresponding tandem options to the total number of manager options (including manager options underlying such tandem awards subject to corresponding tandem options) multiplied by (ii) 30 (such period, the "Manager Exercisability Period"). Following the Manager Exercisability Period, the tandem awards vest in monthly installments on the first of each month over the remainder of the Total Exercisability Period and become exercisable only at the end of the Total Exercisability Period. F3 · derivative.expiration_date: Represents the expiration date of the related manager option. In general, the expiration date of the tandem award occurs prior to the expiration date of the underlying option. F4 · derivative.underlying: Tandem awards will be settled in an amount of cash equal to the excess of the fair market value of a share of our common stock on the date of exercise over the fair market value on the date of grant, unless advance approval is given by the Board of Directors or an officer of the Company, as applicable, to settle the tandem awards in shares. Read SEC document |
| March 16, 2021 Filed Mar 17, 2021 20:18 UTC |
Nierenberg MichaelDirector · Chairman, CEO & President
|
GrantStock Option (right to buy) · Derivative | 280,000 | $0.00 Strike: $17.41 | $0.00 |
DisclosureSEC source: 0001209191-21-021321 · doc4.xml · derivative · entry 1 Nierenberg Michael · CIK 0001591719 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,000 Underlying: Common Stock, par value $0.01 per share · 280,000 shares Expires 2030-02-14 F1 · derivative.exercise_date: Tandem awards correspond on a one-to-one basis with options granted to FIG LLC, the Company's manager (or an affiliate of the Company's manager), such that exercise by an employee of the tandem award would result in the corresponding option held by the manager being cancelled. Upon the grant of options to the manager (or an affiliate), such options are fully vested and become exercisable over a 30-month period (the "Total Exercisability Period") in monthly installments beginning on the first of each month following the month in which the options were granted. (Continued in Footnote 2) F2 · derivative.exercise_date: When tandem awards are granted with respect to manager options, the manager options become exercisable in monthly installments over a portion of the Total Exercisability Period equal to the product of (i) the ratio of manager options not subject to corresponding tandem options to the total number of manager options (including manager options underlying such tandem awards subject to corresponding tandem options) multiplied by (ii) 30 (such period, the "Manager Exercisability Period"). Following the Manager Exercisability Period, the tandem awards vest in monthly installments on the first of each month over the remainder of the Total Exercisability Period and become exercisable only at the end of the Total Exercisability Period. F3 · derivative.expiration_date: Represents the expiration date of the related manager option. In general, the expiration date of the tandem award occurs prior to the expiration date of the underlying option. F4 · derivative.underlying: Tandem awards will be settled in an amount of cash equal to the excess of the fair market value of a share of our common stock on the date of exercise over the fair market value on the date of grant, unless advance approval is given by the Board of Directors or an officer of the Company, as applicable, to settle the tandem awards in shares. Read SEC document |
| January 29, 2021 Filed Feb 4, 2022 21:46 UTC |
LENEHAN PAMELA FDirector
|
OtherCommon Stock | 705 | $9.51 | $6,704.76 |
DisclosureSEC source: 0001209191-22-007207 · doc5.xml · nonDerivative · entry 1 LENEHAN PAMELA F · CIK 0001202481 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,192 F1 · balance_after: Amount includes shares acquired by the Reporting Person after Issuer's fiscal year end. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 13:05 UTC |
LENEHAN PAMELA FDirector
|
GrantCommon Stock | 10,549 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-000627 · doc4.xml · nonDerivative · entry 1 LENEHAN PAMELA F · CIK 0001202481 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,837 F1 · price: The shares were issued to director as compensation for services provided to the issuer in accordance with the issuer's Incentive Award Plan and the additional terms established by resolution of the Board of Directors. The applicable closing stock price was $9.48 on January 4, 2021. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 13:01 UTC |
Finnerty Kevin JDirector
|
GrantCommon Stock | 10,549 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-000624 · doc4.xml · nonDerivative · entry 1 Finnerty Kevin J · CIK 0001335440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,580 F1 · price: The shares were issued to director as compensation for services provided to the issuer in accordance with the issuer's Incentive Award Plan and the additional terms established by resolution of the Board of Directors. The applicable closing stock price was $9.48 on January 4, 2021. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 08:13 UTC |
MCGINNIS ROBERTDirector
|
GrantCommon Stock | 10,549 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-000629 · doc4.xml · nonDerivative · entry 1 MCGINNIS ROBERT · CIK 0001525863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,423 F1 · price: The shares were issued to director as compensation for services provided to the issuer in accordance with the issuer's Incentive Award Plan and the additional terms established by resolution of the Board of Directors. The applicable closing stock price was $9.48 on January 4, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.